![Talon Therapeutics, Inc. Logo](/news-release/logo/214358/0/214358.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A02&size=2)
Talon Therapeutics Receives Special Protocol Assessment Agreement from the Food and Drug Administration for Its Phase 3 Confirmatory Study of Marqibo(R) in Newly Diagnosed Acute Lymphoblastic Leukemia
29 août 2011 09h00 HE
|
Talon Therapeutics, Inc.
SAN MATEO, Calif., Aug. 29, 2011 (GLOBE NEWSWIRE) -- Talon Therapeutics, Inc., (OTCBB:TLON), announced today the company has reached agreement with the U. S. Food and Drug Administration (FDA)...
![Talon Therapeutics, Inc. Logo](/news-release/logo/214358/0/214358.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A02&size=2)
Talon Therapeutics, Inc. Reports Second Quarter 2011 Financial Results
15 août 2011 09h00 HE
|
Talon Therapeutics, Inc.
SAN MATEO, Calif., Aug. 15, 2011 (GLOBE NEWSWIRE) -- Talon Therapeutics, Inc., (OTCBB:TLON), today reported financial results for the three and six months ended June 30, 2011.
"Submitting our new...
![Talon Therapeutics, Inc. Logo](/news-release/logo/214358/0/214358.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A02&size=2)
Talon Therapeutics to Host a Conference Call to Report Second Quarter 2011 Financial Results and Business Update on August 15, 2011
09 août 2011 09h00 HE
|
Talon Therapeutics, Inc.
SAN MATEO, Calif., Aug. 9, 2011 (GLOBE NEWSWIRE) -- Talon Therapeutics, Inc. (OTCBB:TLON) will host a conference call on Monday, August 15, 2011 at 8:30AM PT, to include a discussion of results and...
![Talon Therapeutics, Inc. Logo](/news-release/logo/214358/0/214358.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A02&size=2)
Talon Therapeutics Announces First Patient Enrolled in National Cancer Institute Phase 1 Trial of Marqibo(R) in Children and Adolescents
20 juil. 2011 09h00 HE
|
Talon Therapeutics, Inc.
SAN MATEO, Calif., July 20, 2011 (GLOBE NEWSWIRE) -- Talon Therapeutics, Inc. (OTCBB:TLON) today announced the enrollment of the first patient in a Phase 1 trial to evaluate the safety, activity and...
![Talon Therapeutics, Inc. Logo](/news-release/logo/214358/0/214358.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A02&size=2)
Talon Therapeutics Submits New Drug Application for Marqibo(R)
18 juil. 2011 09h00 HE
|
Talon Therapeutics, Inc.
SAN MATEO, Calif., July 18, 2011 (GLOBE NEWSWIRE) -- Talon Therapeutics, Inc. (OTCBB:TLON) today announced its New Drug Application (NDA) for Marqibo (vincristine sulfate liposomes injection) was...
![Talon Therapeutics, Inc. Logo](/news-release/logo/214358/0/214358.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A02&size=2)
Talon Therapeutics Provides NDA Submission Timeline Update for Marqibo(R)
30 juin 2011 09h00 HE
|
Talon Therapeutics, Inc.
SAN MATEO, Calif., June 30, 2011 (GLOBE NEWSWIRE) -- Talon Therapeutics, Inc. (OTCBB:TLON) today provided an update of the status of its planned NDA submission for Marqibo ((vincristine sulfate...
![Talon Therapeutics, Inc. Logo](/news-release/logo/214358/0/214358.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A02&size=2)
Talon Therapeutics Presents Marqibo(R) Hematopoietic Stem Cell Transplantation (HSCT) "Bridging" Data at American Society of Clinical Oncology 2011 Annual Meeting
06 juin 2011 09h00 HE
|
Talon Therapeutics, Inc.
Marqibo enabled bridging to HSCT in 12 of 65 (18.5%) patients
There were 5 long-term survivors (greater than one year survival)
SAN MATEO, Calif., June 6, 2011 (GLOBE NEWSWIRE) -- Talon...
![Talon Therapeutics, Inc. Logo](/news-release/logo/214358/0/214358.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A02&size=2)
Talon Therapeutics, Inc. Reports First Quarter 2011 Financial Results
13 mai 2011 09h00 HE
|
Talon Therapeutics, Inc.
SAN MATEO, Calif., May 13, 2011 (GLOBE NEWSWIRE) -- Talon Therapeutics, Inc. (OTCBB:TLON), today reported financial results for the first quarter ended March 31, 2011.
"Our primary focus for the...
![Talon Therapeutics, Inc. Logo](/news-release/logo/214358/0/214358.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A02&size=2)
Talon Therapeutics to Commence a Phase 3 Study of Marqibo(R) in Adult Patients With Newly Diagnosed Non-Hodgkin's Lymphoma (NHL)
10 mai 2011 09h00 HE
|
Talon Therapeutics, Inc.
Conducted by the prestigious German High-Grade NHL Study Group
R-CHMP (M=Marqibo) versus R-CHOP (O=standard vincristine)
Enrollment anticipated in third quarter 2011
SAN MATEO, Calif.,...
![Talon Therapeutics, Inc. Logo](/news-release/logo/214358/0/214358.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A02&size=2)
Talon Therapeutics to Host a Conference Call to Report First Quarter 2011 Financial Results and Business Update on May 13, 2011
09 mai 2011 09h00 HE
|
Talon Therapeutics, Inc.
SAN MATEO, Calif., May 9, 2011 (GLOBE NEWSWIRE) -- Talon Therapeutics, Inc. (OTCBB:TLON) will host a conference call on Friday, May 13, 2011 at 8AM PT, to include a discussion of results and...